USP14 and neoplasm: While high expression levels of USP14 are closely correlated with poor prognosis and follow tumor disease progression, its activity was increased in tumor cells as compared to normal melanocyte cells and in BRAFi-resistant cells as compared to the parental cells, resulting in higher responsiveness to b-AP15.